PharmAnt is the trusted news hub of the pharma sector

Recent Pharma Sector News

Leave a Reply

Your email address will not be published. Required fields are marked *

You may have missed

Disease Overview: Duchenne muscular dystrophy 7 min read

Disease Overview: Duchenne Muscular Dystrophy

10 months ago Mona Al Absi
Promising Therapeutic Approaches for Spinal Muscular Atrophy (SMA) 7 min read

Promising Therapeutic Approaches for Spinal Muscular Atrophy (SMA)

11 months ago Mona Al Absi
Bylvay for Ipsen approved by FDA 5 min read

FDA Approves Bylvay (Odevixibat) as a Breakthrough Treatment for Cholestatic Pruritus in Alagille Syndrome Patients

12 months ago Mona Al Absi
Comparing Enzalutamide and Flutamide as First-Line Androgen Therapy for Japanese Men with Castration-Resistant Prostate Cancer: A Clinical Study 3 min read

Comparing Enzalutamide and Flutamide as First-Line Androgen Therapy for Japanese Men with Castration-Resistant Prostate Cancer: A Clinical Study

12 months ago Mona Al Absi
PharmAnt© All rights reserved. | Newsphere by AF themes.